Johnson & Johnson trades above 21x forward EPS with $24B in Q3 revenue, and a raised FY25 sales guidance outlook. Read why JNJ stock is downgraded to hold.
Not every business is suited to subscriptions, but in the right industries, the model can drive steady revenue and long-term customer relationships. Not long ago, subscriptions were mostly associated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback